Related Experiment Video
Updated: Jul 18, 2026
04:00
Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment
Published on: July 26, 2024
[Risk factors for mortality among elderly people]
Flávia de O M Maia1, Yeda A O Duarte, Maria Lúcia Lebrão
1Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil. flaviamaia@hu.usp.br
Revista De Saude Publica
|December 19, 2006
Summary
Key risk factors for mortality in older adults include mobility issues, advanced age, male gender, poor self-rated health, and difficulty with daily activities. These findings aid in developing targeted preventive strategies for elderly populations.
Area of Science:
- Gerontology and Public Health
- Epidemiology of Aging
Context:
- Understanding mortality risk factors is crucial for implementing effective preventive health measures in aging populations.
- The study focuses on elderly individuals in São Paulo, Brazil, utilizing data from the SABE (Health, Wellbeing and Aging) study conducted in 2000.
Purpose:
- To identify and analyze the significant risk factors associated with death among the elderly population.
- To provide data that can inform the development of targeted interventions to reduce mortality rates in older adults.
Summary:
- A study of 2,143 elderly participants (aged 60+) in São Paulo revealed significant mortality risk factors: difficulty with locomotion (OR=3.15), advanced age (OR=2.93), male gender (OR=2.90), self-assessed "bad" health (OR=2.69), and difficulty using the bathroom (OR=2.51).
- Logistic regression analysis was employed to determine these associations, with 38 deaths recorded within the study period.
Impact:
- The findings can guide public health initiatives and clinical practices aimed at preventing premature deaths in the elderly.
- Highlights the importance of addressing functional limitations and self-perceived health status in geriatric care and policy-making.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...